Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judit Pallos

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Human Molecular Genetics|August 20, 2003
Fly models of Huntington's diseaseJ Lawrence Marsh, Judit Pallos, Leslie M Thompson
Neurobiology of Disease|May 13, 2021
Dopamine neuron-specific LRRK2 G2019S effects on gene expression revealed by translatome profilingJudit Pallos, Sophia Jeng, Shannon McWeeney, et al.
Neuro-Degenerative Diseases|September 14, 2011
Pcaf modulates polyglutamine pathology in a Drosophila model of Huntington's diseaseLaszlo Bodai, Judit Pallos, Leslie Michels Thompson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2024
Natural variation in age-related dopamine neuron degeneration is glutathione dependent and linked to life spanColin R Coleman, Judit Pallos, Alicia Arreola-Bustos, et al.
Human Molecular Genetics|September 3, 2008
Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's diseaseJudit Pallos, Laszlo Bodai, Tamas Lukacsovich, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Natural Variation in Age-Related Dopamine Neuron Degeneration is Glutathione-Dependent and Linked to Life SpanColin R Coleman, Judit Pallos, Alicia Arreola-Bustos, et al.
Human Molecular Genetics|May 25, 2006
Biologically active molecules that reduce polyglutamine aggregation and toxicityUrvee A Desai, Judit Pallos, Aye Aye K Ma, et al.
Neuron|November 19, 2003
A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitorSonia K Pollitt, Judit Pallos, Jieya Shao, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2005
Identification of combinatorial drug regimens for treatment of Huntington's disease using DrosophilaNamita Agrawal, Judit Pallos, Natalia Slepko, et al.
Human Molecular Genetics|December 7, 2005
Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicityBarbara L Apostol, Katalin Illes, Judit Pallos, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Human Molecular Genetics|August 20, 2003
Fly models of Huntington's diseaseJ Lawrence Marsh, Judit Pallos, Leslie M Thompson
Neurobiology of Disease|May 13, 2021
Dopamine neuron-specific LRRK2 G2019S effects on gene expression revealed by translatome profilingJudit Pallos, Sophia Jeng, Shannon McWeeney, et al.
Neuro-Degenerative Diseases|September 14, 2011
Pcaf modulates polyglutamine pathology in a Drosophila model of Huntington's diseaseLaszlo Bodai, Judit Pallos, Leslie Michels Thompson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2024
Natural variation in age-related dopamine neuron degeneration is glutathione dependent and linked to life spanColin R Coleman, Judit Pallos, Alicia Arreola-Bustos, et al.
Human Molecular Genetics|September 3, 2008
Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's diseaseJudit Pallos, Laszlo Bodai, Tamas Lukacsovich, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Natural Variation in Age-Related Dopamine Neuron Degeneration is Glutathione-Dependent and Linked to Life SpanColin R Coleman, Judit Pallos, Alicia Arreola-Bustos, et al.
Human Molecular Genetics|May 25, 2006
Biologically active molecules that reduce polyglutamine aggregation and toxicityUrvee A Desai, Judit Pallos, Aye Aye K Ma, et al.
Neuron|November 19, 2003
A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitorSonia K Pollitt, Judit Pallos, Jieya Shao, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2005
Identification of combinatorial drug regimens for treatment of Huntington's disease using DrosophilaNamita Agrawal, Judit Pallos, Natalia Slepko, et al.
Human Molecular Genetics|December 7, 2005
Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicityBarbara L Apostol, Katalin Illes, Judit Pallos, et al.
Pageof 2